AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Webinar: PrEP Initiation and Adherence among Black Men who have Sex with Men (BMSM) in Three U.S. Cities

HIV Prevention Trails Network 073

Please join the HIV Prevention Trials Network (HPTN) launch of a Pre-Exposure Prophylaxis (PrEP) study for Black men who have sex with men (BMSM). The new study, HPTN 073, is a demonstration project designed to see if BMSM are willing to use Truvada® for PrEP. Date: Wed, Aug 14, 2013 Time: 2:00 PM EDT Duration: 1 hour 30 minutes…

FDA approves first rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies

FDA

The U.S. Food and Drug Administration today approved the first rapid Human Immunodeficiency Virus (HIV) test for the simultaneous detection of HIV-1 p24 antigen as well as antibodies to both HIV-1 and HIV-2 in human serum, plasma, and venous or fingerstick whole blood specimens. Approved for use as an aid in the diagnosis of HIV-1…

Dr. Carl Dieffenbach: Key Developments in HIV Research from IAS 2013

IAS Day 2

Last week, Dr. Carl Dieffenbach from NIH/NIAID shared brief reports from the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2013) with the AIDS.gov community via Skype. As Dr. Dieffenbach related, some key highlights of the conference included: Long-term HIV treatment strategies to address HIV as a chronic management disease; The…

Dr. Carl Dieffenbach: IAS Conference Highlights HIV Treatment Advances – Day 4

7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia.

Today was the final day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID, to share daily dispatches from this important scientific conference via Skype. As Dr. Dieffenbach related, research related to significant HIV treatment advances has been a major…

Dr. Carl Dieffenbach: 7th International AIDS Society (IAS) Conference Addresses Social Determinants of Health – Day 3

IAS 2013

Yesterday, July 2, was the second full day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID to share daily highlights from this important scientific conference via Skype. As Dr. Dieffenbach shared, researchers at the conference discussed the social determinants of…

Dr. Carl Dieffenbach: 7th International AIDS Society (IAS) Conference Highlights Value of Treatment Cascade – Day 2

IAS Day 2

Yesterday, July 1, was the first full day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia—the world’s largest scientific conference on HIV/AIDS. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID, to share daily highlights from the conference via Skype. Dr. Dieffenbach relayed that one of the themes…

Highlights from the 7th International AIDS Society (IAS) Conference Opening Session

International AIDS Society Day 1

June 30, 2013, was the opening plenary of the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. We asked Dr. Carl Dieffenbach, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), to share highlights from the conference via Skype. Please…

FDA approves first genotyping test for patients with hepatitis C virus

FDA

The U.S. Food and Drug Administration today approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying. The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5,using a sample of an infected patient’s blood plasma or serum, will aid health…

Page 4 of 19« First...3456...10...Last »